Related Experiment Video
Updated: Dec 13, 2025

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19
Gayatri Setia1, Jeffrey Tyler2, Alan Kwan2
1Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Insights
Thrombolysis may be insufficient for ST-elevation myocardial infarction (STEMI) in COVID-19 patients. Early invasive hemodynamics are crucial for managing distributive shock in these complex cases.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- ACC/SCAI guidelines recommend thrombolysis for COVID-19 patients with ST-elevation myocardial infarction (STEMI).
- This case examines the management of a patient with concurrent COVID-19 and STEMI.
Observation:
- The patient received initial treatment with thrombolysis and anticoagulation.
- Persistent thrombus burden necessitated subsequent thrombectomy and stent placement.
- Invasive hemodynamics revealed a high cardiac output state with low systemic vascular resistance, indicative of distributive shock.
Findings:
- Thrombolytic therapy alone proved inadequate for this STEMI patient with COVID-19.
- Early invasive hemodynamic assessment was vital for diagnosing distributive shock.
- The patient's shock was characterized by high cardiac output and low systemic vascular resistance.
Implications:
- Thrombolysis may not be sufficient as a sole reperfusion strategy for STEMI in COVID-19 patients.
- Early invasive hemodynamic monitoring is essential for effective shock management in patients with STEMI and COVID-19.
- This case highlights the complex interplay between COVID-19 infection and acute cardiovascular events.
Abstract:
Consideration of thrombolysis as first-line reperfusion therapy in patients with COVID-19 and STEMI is recommended by ACC/SCAI guidelines. We describe a patient with COVID-19, who presented with ST-elevation myocardial infarction and was treated with thrombolysis and anticoagulation. He was later found to have a significant persistent thrombus burden requiring thrombectomy and stent placement. Invasive hemodynamics on multiple high-dose pressers revealed a high cardiac output state with low systemic vascular resistance, consistent with distributive rather than cardiogenic shock. Our case illustrates that thrombolytic therapy alone may not be adequate in patients with STEMI and COVID-19, as well as the importance of early invasive hemodynamics in management of shock in patient with STEMI and COVID-19 infection.
Related Concept Videos
Myocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis I: Introduction

